Modelled on Harrington Discovery Institute’s US sister programme, Fund for Cures UK is a not-for-profit organisation dedicated to supporting academic researchers and breakthrough discovery in the United Kingdom.
Fund for Cures UK provides non-dilutive financial capital, industry-experienced guidance, and business management needed to advance basic drug discoveries into the clinical realm. We’ll help move your project beyond the high-risk, early stages of drug development to the point where the pharmaceutical industry will invest to bring the drugs to market.
The Therapeutics Development Center (TDC) advisors and project managers work closely with Harrington Scholars to move their projects toward the clinic and enhance potential for commercial success. TDC advisors are experienced leaders from top pharma companies with a track record of bringing new drugs to market.
Scholar support includes:
To see how the Therapeutics Development Center supports scholars, watch Drs. Haiyan Zhou and Siew Peng Ho as they present Dr. Zhou's project in the 2022 Rare Disease Day webinar.
Combining excellence in research and drug development to cure rare diseases worldwide
The Oxford-Harrington Rare Disease Centre (OHC) is a collaboration between the University of Oxford and Harrington Discovery Institute. This partnership combines world-leading strengths in research and therapeutics development. The Centre will advance knowledge into cures for rare diseases across the United Kingdom and the United States.
We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. It is mandatory to procure user consent prior to running these cookies on your website.